Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 5Phase 1 3Phase 1/2 2Phase 4 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Dermatologic 2Plasma cell 1Lymphoid 1Genitourinary 1CNS 1Breast 1

Conditions

Sarcoma 2Melanoma 2Neoplasms 1Multiple Myeloma 1Meningeal Carcinomatosis 1Lymphoma 1Kidney Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Interferons × Clear all
NCT07199413 2025-09-30

Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases

Medical College of Wisconsin

Phase 1 Not yet recruiting
20 enrolled
CNS

Brain Neoplasms, Meningeal Carcinomatosis

NCT00311558 2018-01-26

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

The Cleveland Clinic

Phase 1 Terminated
18 enrolled
DermatologicSarcoma

Melanoma, Neoplasms, Sarcoma

NCT00276536 2015-10-14

IFNa

The Cleveland Clinic

Phase 1 Completed
35 enrolled
BreastDermatologicGenitourinaryLymphoidPlasma cellSarcoma

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡